Skip to main content
ARTRYA LIMITED logo

ARTRYA LIMITED — Investor Relations & Filings

Ticker · AYA ISIN · AU0000182412 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 322 across all filing types
Latest filing 2026-05-18 Major Shareholding Noti…
Country AU Australia
Listing ASX AYA

About ARTRYA LIMITED

https://artrya.com

Artrya Limited is a medical technology company focused on the development of artificial intelligence solutions for the detection and management of coronary artery disease. The company's flagship platform, Artrya Salix, utilizes deep learning algorithms to automate the analysis of Computed Tomography Coronary Angiography (CTCA) scans. This technology is designed to assist clinicians by identifying and quantifying key markers of heart disease, including coronary artery stenosis and high-risk vulnerable plaque, which are often difficult to detect through manual review. By providing rapid, non-invasive, and objective assessments, the platform aims to improve diagnostic accuracy, streamline clinical workflows, and support early intervention strategies for patients at risk of major adverse cardiac events. The software integrates into existing clinical environments to provide point-of-care decision support for radiologists and cardiologists.

Recent filings

Filing Released Lang Actions
Ceasing to be a substantial holder 8 pages 217.4KB
Major Shareholding Notification Classification · 95% confidence The document is an Australian 'Form 605 – Notice of ceasing to be a substantial holder' under Corporations Law Section 671B, detailing changes in relevant interests and the fall below a substantial shareholding threshold. This clearly falls under Major Shareholding Notification, not a financial report or announcement of a report publication.
2026-05-18 English
Artrya appoints Clayton Hatch as Chief Financial Officer 2 pages 181.0KB
Board/Management Information Classification · 91% confidence The document is an ASX announcement detailing the appointment of Clayton Hatch as Chief Financial Officer of Artrya. It focuses solely on a senior management change with background info on the incoming and outgoing officers. There are no financial statements, investor materials, or regulatory filing requirements beyond the management appointment notice. This falls under the Board/Management Information category.
2026-05-17 English
March Quarterly Activities Report and Appendix 4C 10 pages 502.6KB
Regulatory Filings
2026-04-29 English
Issue of Shares and Cleansing Notice 2 pages 145.3KB
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from Artrya Limited regarding the issue of 500,000 ordinary shares on exercise of options by a director, Bernie Ridgeway. It includes a cleansing notice and a secondary trading notice pursuant to the Corporations Act 2001. The content focuses on share issuance, compliance with disclosure requirements, and notification of director's interest changes. There are no financial statements, earnings data, or detailed financial analysis present. The document is relatively short (4461 characters) and serves as a formal announcement of a capital change event rather than a full report or detailed financial disclosure. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2026-04-13 English
Application for quotation of securities - AYA 8 pages 21.4KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and is an official announcement from ARTRYA LIMITED dated April 14, 2026. It details the application for quotation of securities on the ASX, specifically securities issued due to options being exercised or convertible securities being converted. The document includes specifics about the number and type of securities, issue price, and details about key management personnel involved. This type of document is a formal application to list or quote new or additional securities on the stock exchange, which corresponds to announcements about share issues or capital changes. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about capital changes. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and detail confirm it is not a brief notice but a full application form, supporting high confidence in classification.
2026-04-13 English
Change of Director's Interest Notice - B Ridgeway 3 pages 291.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including shares and options acquired and disposed of, with specific dates and quantities. This matches the definition of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). The document is about a director's change in interest in securities, not an announcement of a report or a general regulatory filing. Therefore, the correct classification is DIRS.
2026-04-13 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.